Direct determination of naftopidil by non-protected fluid room temperature phosphorescence

Abstract

A selective and sensitive room temperature phosphorimetric method for the direct determination of naftopidil in biological fluids is described. The method is based on obtaining a phosphorescence signal from this antihypertensive drug using TlNO3 as a heavy atom perturber and Na2SO3 as a deoxygenator agent without a protective medium. This technique is named non-protected room temperature phosphorescence (NP-RTP), and enables us to determine analytes in complex matrices without the need for a tedious prior separation process. The optimization of Na2SO3 (8.5 x 10(-3) M) and the accurate value of pH (9.0) were determined using a simplex as a method of optimization. Sodium carbonate-hydrogencarbonate buffer solution (5.0 x 10(-2) M) was used to adjust the suitable pH. The optimum concentration of Tl+ (8.5 x 10(-2) M) was also determined. The delay time, gate time and time between flashes selected were 200 microseconds, 200 microseconds and 5 ms, respectively. Under the above conditions we propose a method to determine naftopidil by direct measurement of phosphorescence intensity with an emission wavelength of 526 nm and an excitation wavelength of 296 nm in the concentration range 0.05-1.00 mg L-1. Under these conditions the phosphorescence signal appears in 3 min once the sample has been prepared. Optimization of the various conditions permitted the establishment of an NP-RTP method for the determination with a detection limit, according to the error propagation theory, of 21.0 ng mL-1. The repeatability was studied using 10 solutions of 0.20 mg L-1 of naftopidil; if error propagation is assumed, the relative error is 1.39%. The standard deviation for replicate samples was 1.1 x 10(-2) mg L-1. This method was successfully applied to the determination of naftopidil, in human urine with recoveries between 106 and 112%.

Multi-criteria decision making approach and experimental design as chemometric tools to optimize HPLC separation of domperidone and pantoprazole

“…For specificity study, placebo containing starch, lactose monohydrate, aerosil, hydroxy propyl methylcellulose, titanium dioxide and magnesium stearate was used. The homoscedasticity for the calibration curves was tested using Cochran's test [23] at the level of 95% significance. Calibration curves were constructed in a low region of 0.05-1.0% of the target analyte concentration for the limit of detection and quantification [24].…”

Development and validation of a HPLC-UV method for the determination in didanosine tablets

“…Characteristic parameters for regression equation (y = a + bx) of the HPLC method obtained by least squares treatment of the results was used to confirm the good linearity of the method developed. The homoscedasticity for the calibration curve was tested using Cochran's test (G = largest variance/sum of variances) [14].…”

An improved HPLC method with the aid of a chemometric protocol: Simultaneous analysis of amlodipine and atorvastatin in pharmaceutical formulations

“…For both analytes, the calculated F-value (F Calc ) was found to be less than the theoretical F-value (F Crit ) at 5% significance levels, indicating that there was no significant difference between replicate determinations for each concentration levels ( Table 7). The homoscedasticity for the calibration curves was verified by applying Cochran's test and in that no statistical difference (P A 0.05) was found between variances [40,41].…”